Literature DB >> 14057861

THE PRESENCE OF TWO PERMEABILITY GLOBULINS IN HUMAN SERUM.

L J KAGEN, J P LEDDY, E L BECKER.   

Abstract

Entities:  

Keywords:  BLOOD PROTEIN ELECTROPHORESIS; BRADYKININ; CAPILLARY PERMEABILITY; CHROMATOGRAPHY; DIPHENHYDRAMINE; ENZYME INHIBITORS; GLOBULINS; KALLIKREIN; PERMEABILITY; SERUM GLOBULINS

Mesh:

Substances:

Year:  1963        PMID: 14057861      PMCID: PMC289405          DOI: 10.1172/JCI104819

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  11 in total

1.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum.

Authors:  A A MILES; D L WILHELM
Journal:  Br J Exp Pathol       Date:  1955-02

2.  Action of the kallikreins on synthetic ester substrates.

Authors:  M E WEBSTER; J V PIERCE
Journal:  Proc Soc Exp Biol Med       Date:  1961-05

3.  Actions of pure bradykinin.

Authors:  D F ELLIOTT; E W HORTON; G P LEWIS
Journal:  J Physiol       Date:  1960-10       Impact factor: 5.182

4.  Bradykinin as a vasodilator in man.

Authors:  R H FOX; R GOLDSMITH; D J KIDD; G P LEWIS
Journal:  J Physiol       Date:  1961-08       Impact factor: 5.182

5.  Enzymic nature of the serum globulin permeability factor.

Authors:  E L BECKER; D L WILHELM; A A MILES
Journal:  Nature       Date:  1959-05-02       Impact factor: 49.962

6.  Augmentation of the inflammatory reaction by activity of the central nervous system.

Authors:  L F CHAPMAN; H GOODELL; H G WOLFF
Journal:  Arch Neurol       Date:  1959-11

7.  Susceptibility of the guinea pig to pharmacological factors from its own serum.

Authors:  M E MACKAY; A A MILES; M SCHACHTER; D L WILHELM
Journal:  Nature       Date:  1953-10-17       Impact factor: 49.962

8.  [Chemical and pharmacologic differentiation of kallikreins of various origins].

Authors:  E WERLE; L MAIER
Journal:  Biochem Z       Date:  1952

9.  Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein.

Authors:  N S LANDERMAN; M E WEBSTER; E L BECKER; H E RATCLIFFE
Journal:  J Allergy       Date:  1962 Jul-Aug

10.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

View more
  10 in total

1.  The relationship between the permeability-increasing and the hypotensive proteases of plasma.

Authors:  B Mason; E M Sparrow
Journal:  Br J Pharmacol Chemother       Date:  1965-08

2.  Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.

Authors:  R W Colman; L Mattler; S Sherry
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

3.  Separation of kinin-forming factors in human plasma.

Authors:  V Eisen; K L Glanville
Journal:  Br J Exp Pathol       Date:  1969-10

Review 4.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

Review 5.  Acute inflammation. A review.

Authors:  G B Ryan; G Majno
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

6.  Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

7.  Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.

Authors:  M R Klemperer; V H Donaldson; F S Rosen
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

8.  Guinea pig Hageman factor as a vascular permeability enhancement factor.

Authors:  T Yamamoto; C G Cochrane
Journal:  Am J Pathol       Date:  1981-11       Impact factor: 4.307

9.  Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.

Authors:  P C Harpel
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

10.  Release of kallikrein from guinea pig lung during anaphylaxis.

Authors:  O Jonasson; E L Becker
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.